Parallel Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.76M | Buy |
56,169
+3,968
| +8% | +$458K | 0.12% | 126 |
|
|
2025
Q4 | $5.49M | Buy |
52,201
+4,179
| +9% | +$392K | 0.1% | 147 |
|
|
2025
Q3 | $4.03M | Buy |
48,022
+1,036
| +2% | +$85.3K | 0.07% | 178 |
|
|
2025
Q2 | $3.72M | Sell |
46,986
-7,640
| -14% | -$607K | 0.07% | 183 |
|
|
2025
Q1 | $4.9M | Sell |
54,626
-4,299
| -7% | -$401K | 0.11% | 140 |
|
|
2024
Q4 | $5.86M | Sell |
58,925
-753
| -1% | -$77.6K | 0.13% | 123 |
|
|
2024
Q3 | $6.78M | Sell |
59,678
-1,105
| -2% | -$131K | 0.16% | 111 |
|
|
2024
Q2 | $7.52M | Buy |
60,783
+2,248
| +4% | +$290K | 0.19% | 94 |
|
|
2024
Q1 | $7.72M | Buy |
58,535
+4,896
| +9% | +$603K | 0.21% | 90 |
|
|
2023
Q4 | $5.85M | Sell |
53,639
-530
| -1% | -$55K | 0.17% | 101 |
|
|
2023
Q3 | $5.58M | Sell |
54,169
-1,992
| -4% | -$215K | 0.19% | 102 |
|
|
2023
Q2 | $6.48M | Buy |
56,161
+670
| +1% | +$76.1K | 0.21% | 94 |
|
|
2023
Q1 | $5.9M | Buy |
55,491
+2,996
| +6% | +$323K | 0.2% | 99 |
|
|
2022
Q4 | $5.82M | Buy |
52,495
+3,250
| +7% | +$332K | 0.25% | 67 |
|
|
2022
Q3 | $4.24M | Buy |
49,245
+9,242
| +23% | +$825K | 0.2% | 82 |
|
|
2022
Q2 | $3.65M | Buy |
40,003
+1,788
| +5% | +$159K | 0.17% | 89 |
|
|
2022
Q1 | $3.15M | Buy |
38,215
+823
| +2% | +$64.9K | 0.12% | 120 |
|
|
2021
Q4 | $2.87M | Sell |
37,392
-3,933
| -10% | -$313K | 0.11% | 137 |
|
|
2021
Q3 | $3.1M | Buy |
41,325
+3,071
| +8% | +$234K | 0.13% | 122 |
|
|
2021
Q2 | $2.98M | Buy |
38,254
+6,364
| +20% | +$473K | 0.13% | 123 |
|
|
2021
Q1 | $2.35M | Sell |
31,890
-1,595
| -5% | -$118K | 0.11% | 138 |
|
|
2020
Q4 | $2.61M | Sell |
33,485
-4,903
| -13% | -$375K | 0.14% | 111 |
|
|
2020
Q3 | $3.04M | Sell |
38,388
-660
| -2% | -$51.7K | 0.19% | 82 |
|
|
2020
Q2 | $2.88M | Buy |
39,048
+3,105
| +9% | +$234K | 0.19% | 83 |
|
|
2020
Q1 | $2.64M | Buy |
35,943
+853
| +2% | +$67K | 0.21% | 73 |
|
|
2019
Q4 | $3.04M | Buy |
35,090
+1,310
| +4% | +$108K | 0.23% | 78 |
|
|
2019
Q3 | $2.71M | Buy |
33,780
+1,506
| +5% | +$121K | 0.23% | 76 |
|
|
2019
Q2 | $2.58M | Sell |
32,274
-3,188
| -9% | -$244K | 0.25% | 68 |
|
|
2019
Q1 | $2.81M | Sell |
35,462
-430
| -1% | -$32.2K | 0.32% | 60 |
|
|
2018
Q4 | $2.62M | Buy |
35,892
+3,325
| +10% | +$235K | 0.36% | 50 |
|
|
2018
Q3 | $2.2M | Buy |
32,567
+1,324
| +4% | +$84.4K | 0.27% | 65 |
|
|
2018
Q2 | $1.81M | Buy |
31,243
+1,673
| +6% | +$94.4K | 0.26% | 68 |
|
|
2018
Q1 | $1.54M | Sell |
29,570
-750
| -2% | -$40.5K | 0.24% | 80 |
|
|
2017
Q4 | $1.63M | Buy |
30,320
+68
| +0.2% | +$3.77K | 0.27% | 70 |
|
|
2017
Q3 | $1.59M | Sell |
30,252
-1,488
| -5% | -$90.2K | 0.27% | 68 |
|
|
2017
Q2 | $1.94M | Buy |
31,740
+1,562
| +5% | +$95.1K | 0.36% | 55 |
|
|
2017
Q1 | $1.83M | Buy |
30,178
+2,751
| +10% | +$167K | 0.36% | 59 |
|
|
2016
Q4 | $1.54M | Buy |
+27,427
| New | +$1.61M | 0.36% | 57 |
|
Other funds holding MRK
VCM
VPM
Parallel Advisors's MRK Position: Q1 2026 in Review
Parallel Advisors increased its Merck (MRK) stake by 7.6% in Q1 2026, buying an estimated $458K and bringing the position to 56,169 shares worth $6.76M. The position accounts for 0.12% of the portfolio, ranked #126.
Parallel Advisors first reported a position in MRK in Q4 2016 and has held it in 38 quarters since. The position peaked at $7.72M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Parallel Advisors held 56,169 shares of Merck worth $6.76M as of Q1 2026.
- Parallel Advisors bought 3,968 Merck shares in Q1 2026, an estimated $458K.
- Merck made up 0.12% of Parallel Advisors's portfolio in Q1 2026, its #126 holding.
- Parallel Advisors first reported a position in Merck in Q4 2016 and has held it in 38 quarters since.
- Parallel Advisors's Merck position peaked at $7.72M in Q1 2024.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.